Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Annals of Neurology|June 10, 2014
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosisLuisa M Villar, Bonaventura Casanova, Nadia Ouamara, et al.
Brain, Behavior, and Immunity|July 6, 2026
Temelimab versus placebo in patients with post-COVID conditionMayssam Nehme, Margret Hund-Georgiadis, Esther Del Corral Beamonte, et al.
Annals of Neurology|June 17, 2022
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple SclerosisReza Rahmanzadeh, Riccardo Galbusera, Po-Jui Lu, et al.
Annals of Neurology|March 16, 2022
Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MSJohanna Oechtering, Therese Lincke, Sabine Schaedelin, et al.
Neurology|June 5, 2021
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple SclerosisPietro Maggi, Jens Kuhle, Sabine Schädelin, et al.
Clinical Chemistry and Laboratory Medicine|December 26, 2025
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controlsEline A J Willemse, Sofia Sandgren, Pascal Benkert, et al.
Brain : a Journal of Neurology|September 24, 2025
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosisRoberto Furlan, Sabine Schaedelin, Jette Lautrup Frederiksen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 23, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and BeyondJohanna Oechtering, Sabine Anna Schaedelin, Aleksandra Maleska Maceski, et al.
The Lancet. Neurology|February 19, 2022
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation studyPascal Benkert, Stephanie Meier, Sabine Schaedelin, et al.
Trials|September 11, 2024
MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trialPerrine Janiaud, Chiara Zecca, Anke Salmen, et al.
Pageof 16